1. Home
  2. VSECU vs ANIP Comparison

VSECU vs ANIP Comparison

Compare VSECU & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VSE Corporation Tangible Equity Units

VSECU

VSE Corporation Tangible Equity Units

N/A

Current Price

$53.75

Market Cap

1.6B

Sector

N/A

ML Signal

N/A

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$82.10

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSECU
ANIP
Founded
N/A
2001
Country
United States
United States
Employees
1600
970
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.9B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
VSECU
ANIP
Price
$53.75
$82.10
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$110.00
AVG Volume (30 Days)
38.2K
293.3K
Earning Date
N/A
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
419.23
EPS
N/A
1.28
Revenue
N/A
$206,547,000.00
Revenue This Year
N/A
$21.01
Revenue Next Year
N/A
$17.59
P/E Ratio
N/A
$65.45
Revenue Growth
N/A
2.47
52 Week Low
$38.45
$62.61
52 Week High
$68.10
$99.50

Technical Indicators

Market Signals
Indicator
VSECU
ANIP
Relative Strength Index (RSI) 51.90 48.53
Support Level $44.69 $77.16
Resistance Level $58.94 $83.66
Average True Range (ATR) 3.58 2.64
MACD -0.42 -0.08
Stochastic Oscillator 8.45 39.80

Price Performance

Historical Comparison
VSECU
ANIP

About VSECU VSE Corporation Tangible Equity Units

VSE Corp is a diversified aftermarket products and services company serving commercial and government markets. The Company's operations include aircraft and airframe parts supply and distribution, and MRO services of aircraft components and engine accessories. The Company operates as a single reportable segment: Aviation, which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: